Skip to content

Medical Data Collection for the Evaluation of Radiofrequency Ablation and Cement Augmentation for the Treatment of Secondary Metastases to the Spine

A Single-Center Retrospective Study Evaluating Radiofrequency Ablation and Cement Augmentation for the Treatment of Secondary Metastases to the Spine

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04751422
Enrollment
500
Registered
2021-02-12
Start date
2020-11-13
Completion date
2023-09-30
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Malignant Neoplasm in the Spine

Brief summary

This study collects data on the use of radiofrequency ablation and cement augmentation for the treatment of cancer that has spread to the spine (metastases to the spine). Radiofrequency ablation with cement augmentation is a useful approach for the treatment of secondary metastasis to the spine. Information collected in this study may help doctors to learn the effectiveness of this therapy, and may help to evaluate optimal technique, appropriate patient selection, and management of complications.

Detailed description

PRIMARY OBJECTIVE: I. To evaluate the use of radiofrequency ablation and cement augmentation for the treatment of secondary metastases to the spine. OUTLINE: Patients' medical data is collected retrospectively.

Interventions

OTHERElectronic Health Record Review

Medical data is collected

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients who underwent radiofrequency ablation with cement augmentation at the Department of Interventional Radiology at MD Anderson Cancer Center (MDACC) between 1/1/2017 and 9/26/2020

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Technical successUp to 3 yearsResults will be compared with data available from other published literature.
Clinical successUp to 3 yearsResults will be compared with data available from other published literature.
Complication ratesUp to 3 yearsResults will be compared with data available from other published literature.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026